Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Third Harmonic Bio, Inc. - Common Stock (NQ:THRD)

5.430 +0.005 (+0.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 179,860
Open 5.440
Bid (Size) 5.420 (1)
Ask (Size) 5.500 (8)
Prev. Close 5.425
Today's Range 5.420 - 5.455
52wk Range 3.180 - 16.02
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
From Third Harmonic Bio
Via GlobeNewswire
Top 3 Health Care Stocks You May Want To Dump This Quarter
Via Benzinga

Performance

YTD
-50.8%
-50.8%
1 Month
+4.6%
+4.6%
3 Month
+54.3%
+54.3%
6 Month
-47.4%
-47.4%
1 Year
-58.3%
-58.3%

More News

Read More
Which stocks are moving on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening?
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered
Via Stocktwits
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Plan of Liquidation and Dissolution
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape
Via Benzinga
Tuesday's session: top gainers and losers
Via Chartmill
Tuesday's session: gap up and gap down stocks
Via Chartmill
Which stocks are moving before the opening bell on Tuesday?
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update
From Third Harmonic Bio
Via GlobeNewswire
Acelyrin, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Ingles Markets, Tesla And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio to Participate in Upcoming Investor Conferences in November
From Third Harmonic Bio
Via GlobeNewswire
Third Harmonic Bio Announces Third Quarter 2024 Financial Results
From Third Harmonic Bio
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Third Harmonic Bio to Participate in Upcoming Investor Conferences in September
From Third Harmonic Bio
Via GlobeNewswire

Frequently Asked Questions

Is Third Harmonic Bio, Inc. - Common Stock publicly traded?
Yes, Third Harmonic Bio, Inc. - Common Stock is publicly traded.
What exchange does Third Harmonic Bio, Inc. - Common Stock trade on?
Third Harmonic Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Third Harmonic Bio, Inc. - Common Stock?
The ticker symbol for Third Harmonic Bio, Inc. - Common Stock is THRD on the Nasdaq Stock Market
What is the current price of Third Harmonic Bio, Inc. - Common Stock?
The current price of Third Harmonic Bio, Inc. - Common Stock is 5.430
When was Third Harmonic Bio, Inc. - Common Stock last traded?
The last trade of Third Harmonic Bio, Inc. - Common Stock was at 06/24/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.